泰和科技(300801) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was ¥412,212,849.03, representing a 19.58% increase compared to ¥344,713,088.10 in the same period last year[9] - Net profit attributable to shareholders decreased by 22.80% to ¥37,338,244.06 from ¥48,367,235.52 year-on-year[9] - The net profit after deducting non-recurring gains and losses fell by 28.38% to ¥31,206,119.90 compared to ¥43,571,330.08 in the previous year[9] - Basic and diluted earnings per share both decreased by 22.78% to ¥0.1729 from ¥0.2239[9] - Total operating revenue for Q1 2021 was CNY 412,212,849.03, an increase of 19.6% compared to CNY 344,713,088.10 in Q1 2020[62] - Net profit for Q1 2021 was CNY 37,338,244.06, a decrease of 22.8% from CNY 48,367,235.52 in Q1 2020[64] - Earnings per share for Q1 2021 was CNY 0.1729, down from CNY 0.2239 in Q1 2020[64] Cash Flow - The net cash flow from operating activities significantly declined by 85.63%, amounting to ¥1,498,661.11, down from ¥10,432,725.70[9] - Net cash flow from operating activities decreased to ¥1,498,661.11 from ¥10,432,725.70, a decline of approximately 85.6%[71] - Cash inflow from investment activities surged to ¥733,876,158.91 from ¥162,698,876.07, marking an increase of approximately 351.5%[71] - Net cash flow from investment activities improved to ¥194,027,333.60 from a negative ¥354,310,186.76, indicating a significant turnaround[71] - Total cash and cash equivalents at the end of the period rose to ¥683,492,233.63 from ¥531,493,715.77, an increase of approximately 28.5%[72] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,148,716,624.30, a 1.15% increase from ¥2,124,221,466.53 at the end of the previous year[9] - The company's total equity increased to CNY 1,906,010,779.88 from CNY 1,868,637,033.89, representing a growth of approximately 2%[57] - Total current assets amounted to CNY 1,348,962,959.10, a slight increase from CNY 1,341,309,977.40 as of December 31, 2020, reflecting a growth of approximately 0.5%[54] - Total non-current assets reached CNY 799,753,665.20, up from CNY 782,911,489.13, marking an increase of about 2.3%[55] - Total liabilities as of the end of Q1 2021 were CNY 153,306,274.70, compared to CNY 151,403,105.37 at the end of Q1 2020[63] Shareholder Information - The total number of common shareholders at the end of the reporting period was 15,262[13] - The largest shareholder, Cheng Zhongfa, holds 47.37% of the shares, totaling 102,319,200 shares[13] Research and Development - Research and development expenses rose by 49.74% to ¥16,662,366.99, reflecting increased investment in innovation[19] - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[56] Market and Operational Risks - The company is actively managing raw material price volatility risks through strategic supplier partnerships and procurement strategies[26][27] - The company faces risks from international trade protectionism, which could adversely affect its export business and international market expansion[29] - The company is closely monitoring the impact of the COVID-19 pandemic on its operations, with no significant effects reported so far[36] Strategic Initiatives - The company is expanding its production capacity with ongoing and planned projects, which may lead to increased revenue if market conditions are favorable[31] - The company is planning to develop new products and explore new markets to reduce reliance on international trade[29] - The company has approved a stock incentive plan to motivate and retain key personnel, which may enhance overall performance[41] - The company is enhancing its sales team and project management capabilities to improve market expansion and project execution[33] Fundraising and Investments - The total amount of raised funds is CNY 843.72 million, with CNY 23.70 million invested in the current quarter[45] - Cumulative investment of raised funds reached CNY 388.98 million, accounting for 46.06% of the total raised funds[45] - The annual production capacity project for 280,000 tons of water treatment agents has a total investment of CNY 391.83 million, with CNY 8.09 million invested to date, representing 20.66% of the planned investment[45] - The R&D center construction project has a total investment of CNY 315.49 million, with CNY 5.64 million invested to date, representing 17.84% of the planned investment[45] - As of March 31, 2021, the unused raised funds amount to CNY 242 million, which is allocated for purchasing liquid and high-security financial products[46] Compliance and Governance - The company has not experienced any significant changes in project feasibility or failed to meet planned progress or expected returns for its fundraising projects[46] - There are no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[43] - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[48] - The company has not reported any violations regarding external guarantees during the reporting period[47] - The company has disclosed all relevant information regarding the use of raised funds in a timely, truthful, accurate, and complete manner, with no issues or violations identified[46]